Status:
UNKNOWN
Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients
Lead Sponsor:
Necmettin Erbakan University
Collaborating Sponsors:
Hacettepe University
Turkish Society of Medical Oncology
Conditions:
Breast Cancer
Female
Eligibility:
FEMALE
19-64 years
Brief Summary
Breast cancer is among the most common types of cancer in the world. Factors such as age, reproduction, nutrition, hormonal, and lifestyle factors also play a role in the etiology of breast cancer. Nu...
Detailed Description
The Location of the Research: The research is carried out in Konya Necmettin Erbakan University Meram Faculty of Medicine General Surgery, Medical Oncology, and Biochemistry Departments. After obtaini...
Eligibility Criteria
Inclusion
- Clinical diagnosis of breast cancer for the first time, Non-metastatic, Written informed consent
Exclusion
- Age \< 19 years and \> 64 years, Metastatic, Pregnancy, Lactation, Clinical diagnosis of moderate/severe neurological impairment, Clinical diagnosis of moderate/severe cognitive impairment, Clinical diagnosis of type 1 diabetes mellitus, Clinical diagnosis of type 2 diabetes mellitus, Refusal to participate
Key Trial Info
Start Date :
March 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04716764
Start Date
March 3 2020
End Date
June 30 2023
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)